GENINUS Inc. (KOSDAQ:389030)
South Korea · Delayed Price · Currency is KRW 2,450.00
+155.00 (6.75%)
At close: Jun 30, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 96.51 billion as of July 1, 2026. Its market cap has increased by 24.73% in one year.
Market Cap
96.51B
Enterprise Value
76.76B
Revenue
10.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,450.00
Market Cap Chart
Since November 8, 2021, GENINUS's market cap has decreased from 145.65B to 96.51B, a decrease of -33.74%. That is a compound annual growth rate of -8.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 96.51B | -17.32% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
| Nov 8, 2021 | 145.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 224.42B |
| 3billion | 179.48B |
| Cytogen | 68.06B |
| Inventera | 63.32B |
| GC Medical Science | 62.07B |
| HLB Panagene | 59.64B |
| Protia | 48.88B |
| Seoulin Bioscience | 37.03B |